LXEO · Lexeo Therapeutics, Inc. · Executive Compensation

$2.87 +0.17 (+6.30%) At close · Oct 27 Q2 2026 earnings call transcript

Russell 2000 member Rebalance outlook locked

Market Cap

$221.52M

82.05M

Volume · Oct 27 2.68M Avg daily vol (3M) 1.28M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
R. Nolan Townsend	Chief Executive Officer and Director	$632,700	—	$1,493,488	$1,165,982	$347,985	$10,785	$3,650,940
Jenny R. Robertson	Former Chief Legal Officer	$459,600	—	$485,613	$407,444	$183,840	$609,386	$2,145,883
Louis Tamayo	Chief Financial Officer	$181,818	—	$215,550	$1,066,013	$197,760	$4,774	$1,665,915

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
R. Nolan Townsend	Chief Executive Officer and Director	$600,000	—	$633,500	$2,833,754	$297,000	$10,994	$4,375,248
Jose Manuel Otero	Chief Technical Officer	$268,854	—	$568,438	$2,545,286	$165,300	$7,590	$3,555,468
Eric Adler	Chief Medical Officer and Head of Research	$468,939	—	$456,875	$2,044,217	$171,000	$21,503	$3,162,534
Jenny R. Robertson	Former Chief Legal Officer	$436,500	—	$343,900	$1,532,228	$160,632	$11,850	$2,485,110
Louis Tamayo	Chief Financial Officer	—	—	—	—	—	—	—

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Eric Adler	Chief Medical Officer and Head of Research	$296,500	$234,750	—	$2,419,424	$80,750	$11,400	$3,042,824
R. Nolan Townsend	Chief Executive Officer and Director	$508,000	—	—	$872,883	$347,880	$8,455	$1,737,218
Jose Manuel Otero	Chief Technical Officer	—	—	—	—	—	—	—

Executive changes

Person	Role	Change	Effective	Filed
Dr. Laura Sepp-Lorenzino	director	Appointed	2026-04-28	2026-04-30
Narinder P. Bhalla, M.D.	Chief Medical Officer	Appointed	2026-01-20	2026-01-27
Jose Manuel Otero, Ph.D.	Chief Operating Officer	Appointed	2026-01-02	2026-01-27
Kyle Rasbach	Chief Financial Officer	Resigned	2025-08-15	2025-08-14
Louis Tamayo	Chief Financial Officer	Appointed	2025-08-15	2025-08-14
Kyle Rasbach	Chief Financial Officer	Appointed	2024-12-18	2024-12-19
Tolga Tanguler	director	Appointed	2024-11-11	2024-11-13
Tim Van Hauwermeiren	director	Appointed	2024-07-05	2024-07-08

Leadership

R. Nolan Townsend CEO, Board Member
Kyle Rasbach CFO, Chief Accounting Officer
Louis Tamayo CFO
Jose Manuel Otero COO
Jose Manuel Otero, Ph.D. COO
Brenda Cooperstone Board Member
Continuing Directors Board Member
Dr. Laura Sepp-Lorenzino Board Member
Laura Sepp-Lorenzino Board Member
Mette Kirstine Agger Board Member
Paula HJ Cholmondeley Board Member
Reinaldo Diaz Board Member
Steven Altschuler Board Member
Tim Van Hauwermeiren Board Member
Tolga Tanguler Board Member

Key facts CIK 1907108 CUSIP 52886X107 13F (30d) 17 filings 17 filers Visit website Investor relations